Community-onset healthcare-related urinary tract infections: Comparison with community and hospital-acquired urinary tract infections

Journal of Infection

Volumn 64, Issue 5, 2012, Pages 478-483

  Aguilar Duran, Silvia ^a   Horcajada, Juan P ^a   Sorlí, Luisa ^a   Montero, Milagro ^a   Salvadó, Margarita ^b   Grau, Santiago ^a   Gómez, Julià ^b   Knobel, Hernando ^a  

^a HOSPITAL DEL MAR   (Spain)

^b Laboratori de Referencia de Catalunya   (Spain)

Author keywords

Antimicrobial resistance; Healthcare associated infections; Urinary tract infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CARBAPENEM; CEPHALOSPORIN; CIPROFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMMUNITY ONSET HEALTHCARE RELATED URINARY TRACT INFECTION; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL ACQUIRED URINARY TRACT INFECTION; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEUS; PSEUDOMONAS AERUGINOSA; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 84859839888     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.01.010     Document Type: Article

References (23)

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002, 113(Suppl. 1A):5S-13S.
2. Cohen-Nahum K., Saidel-Odes L., Riesenberg K., Schlaeffer F., Borer A. Urinary tract infections caused by multi-drug resistant Proteus mirabilis: risk factors and clinical outcomes. Infection 2010, 38:41-46.
3. Van der Starre W.R., Van Nieuwkoop C., Paltansing S., Van't Wout J.W., Groeneveld G.H., Becker M.J., et al. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection. J Antimicrob Chemother 2011, 66:650-656.
4. Colodner R., Kometiani I., Chazan B., Raz R. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection 2008, 36:41-45.
5. Killgore K.M., March K.L., Guglielmo B.J. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother 2004, 38:1148-1152.
6. Lin C.Y., Huang S.H., Chen T.C., Lu L.P., Lin W.R., Chen Y.H. Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates. J Microbiol Immunol Infect 2008, 41:325-331.
7. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-adquired infections. Ann Intern Med 2002, 137:791-797.
8. Valles J., Calbo E., Anoro E., Fontanals D., Xercavins M., Espejo E., et al. Bloodstream infections in adults: importance of healthcare-associated infections. J Infect 2008, 56:27-34.
9. Carratalà J., Mykietiuk A., Fernández-Sabé N., Suárez C., Dorca J., Verdaguer R., et al. Heath care-associated pneumonia requiring hospital admission. Arch Intern Med 2007, 167:1393-1399.
10. Estudio de Prevalencia de Infecciones Nosocomiales en España (EPINE) informe global de España 2010, Sociedad Española de Medicina Preventiva, Salud Pública e Higiene.
11. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic morbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
12. Le gall J.R., Lemeshow S., Saulnier F. A new simplified acute physiology score (SAPS II) based on a European /North American multicenter study. JAMA 1993, 270:2957-2963.
13. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control Nov 2008, 36(9):655.
14. Falagas M.E., Koletse P.K., Bliziotis I.A. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 2006, 55:1619-1629.
15. World Health Organization Regional Office for South-East Asia. Guidelines on standard operating procedures for microbiology. New Delhi, India: World Health Organization; Updated 2006 April 27. Available from: http://www.searo.who.int/.
16. Ye H.A., Kang C.I., Joo E.J., Park S.Y., Kang S.J., Wi Y.M., et al. Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis. Scand J Infect Dis 2011, 43:587-595.
17. Enoch D.A., Phillimore N., Mlangeni D.A., Salihu H.M., Sismey A., Aliyu S.H., et al. Outcome for gram-negative bacteraemia when following restrictive empirical antibiotic guidelines. QJM 2011, 104:411-419.
18. Martinez M.A., Inglada L., Ochoa C., Villagrasa J.R., The Spanish Study Group on Antibiotic Treatments Assessment of antibiotic prescription in acute urinary tract infections in adults. J Infect 2007, 54:235-244.
19. Shah B.R., Hux J.E. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003 Feb, 26(2):510-513.
20. Chalmers J.D., Taylor J.K., Singanayagam A., Fleming G.B., Akram A.R., Mandal P., et al. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis 2011, 53:107-113.
21. Ewig S., Welte T., Chastre J., Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010, 10:279-287.
22. Lujan M., Gallego M., Rello J. Healthcare-associated infections. A useful concept?. Curr Opin Crit Care 2009, 15:419-424.
23. Siegman-Igra Y., Fourer B., Orni-Wasserlauf R., Golan Y., Noy A., Schwartz D., et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 2002, 34:1431-1439.